This is the last 2016 publication of the California Oncology Weekly. The next publication will be January 3, 2017.
California employers can read summaries of new legislation taking effect in 2017 that will affect their day-to-day operations. The summaries appear in a California Chamber of Commerce (CalChamber) white paper. For more information click here.
IRS Offers Tips on Validating Your Identity on Your Tax Return. You should always keep a copy of your tax return. It is even more important for 2017, as the Internal Revenue Service moves to strengthen its e-signature validation process. You must use your 2015 adjusted gross income or your 2015 self-select PIN to validate your identity on your federal electronic tax return this tax season. For more information click here.
A study published yesterday in JAMA Internal Medicine suggests that an estimated 32,000 fewer patients would die every year if patient outcomes under male physicians matched those of female physicians. For more information click here.
CMS and the National Library of Medicine (NLM) will update all impacted electronic clinical quality measure (eCQM) value sets for the 2017 performance period. On October 1, 2016, new International Classification of Diseases (ICD)-10-CM and ICD-10-PCS code sets went into effect. Updating of these codes traditionally occurs on an annual basis, however, during the immediate years leading up to the ICD-9 to ICD-10 transition there was an extended freeze to code updates to support a smooth transition.For more information click here.
ASCO is accepting applications for its prestigious Health Policy Fellowship. This isa one-year Fellowship opportunity designed to give early-career oncologists the unique skills necessary to monitor and shape the regulatory and legislative policies that directly affect the practice environment and impact patients with cancer and their care teams. For more information click here.
To view the complete California Oncology Weekly Newsletter click on the date below.
Oncology Revolution: Are your treatment choices still relevant in the era of Immuno-oncology and Molecularly-targeted therapies? Join us for the 2017 MOASC Oncology Summit of Nationally known and regionally based key-opinion leaders and assess your tools for thriving in an era of Personalized Medicine! We will discuss how to use the new tools of “Personalized Medicine” to guide treatment choices for Lung Cancer, Prostate Cancer and Multiple Myeloma. This will be a practically-oriented, clinically relevant discussion and you will leave with new insights into your own practice patterns and how to make sure you are embracing the future today!For more information click here.
Social Security Number Removal Initiative (SSNRI): The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) requires CMS to remove Social Security Numbers (SSNs) from all Medicare cards by April 2019. A new randomly generated Medicare Beneficiary Identifier (MBI) will replace the SSN-based Health Insurance Claim Number on new Medicare cards for transactions like billing, eligibility status, and claim status. For more information click here.
The California Medical Association has released their House of Delegates 2016 House Actions, at CMA’s 145th Annual Session in Sacramento. For more information click here.
Clerical Corrections for Noridian Medicare Portal (NMP): As of October 3, 2016 the portal offers a new “self-service” correction feature which allows providers to reopen a claim and change the modifier, diagnosis, or have a claim reprocessed without using the available re-determination. For more information click here.
NCCN has published updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) with NCCN Evidence Blocks™ for gastric cancer (V3.2016), multiple myeloma (V3.2017). For the complete updated versions of the NCCN Guidelines, NCCN Guidelines with NCCN Evidence Blocks™, the NCCN Compendium®, the NCCN Chemotherapy Order Templates (NCCN Templates®), and the NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC™). For more information click here.
To view the complete California Oncology Weekly Newsletter click, on the date below.
Tomorrow, Wednesday, December 7th, 12:00pm, the California Dialogue on Cancer (CDOC) announces the upcoming webinar: Tobacco Cessation in Cancer Prevention and Treatment: A Call to Action for California Cancer Centers. This webinar will be presented by Elisa Tong, MD, from the University of California Davis, along with California’s Comprehensive Cancer Control Program Director, Shauntay Davis, MPH. For more information click here.
This Saturday, Dec 10th at 9:00 – 11:00am CMA & AMA are co-hosting an educational seminar on MACRA in San Francisco. There is no cost to attend this seminar. As CMS recently issued a final rule outlining the requirements of the new Quality Payment Program (QPP) for physicians that was created by the Medicare Access and CHIP Reauthorization Act (MACRA). For more information click here.
DHCS implemented the first public facing release of PAVE, the department’s new online provider enrollment data management system, on November 18. Over the last few months, the Provider Enrollment Division (PED) and provider users conducted extensive User Acceptance Testing to refine PAVE and prepare it for release. Providers may visit DHCS on Tuesdays each week from Noon to 2 p.m. for hands-on PAVE support, and PED hosts a weekly webinar on Thursdays for providers to call in with PAVE-related questions. For more information click here.
Yesterday, the Senate passed the 21st Century Cures Act. The House of Representatives passed the bill overwhelmingly last week. Vice President Joe Biden took the rare step of presiding over the Senate to oversee the act’s approval of a cloture vote that easily obtained the 60 votes needed to officially end debate on the floor. For more information click here.
Rep. Tom Price, the Georgia Republican and physician picked by President-elect Donald Trump to oversee the health and availability of essential human services to all Americans, belongs to a medical association whose unconventional views are certain to raise questions during his confirmation hearings next year. For more information click here.
To view the complete California Oncology Weekly Newsletter, click on the date below.